Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CRISPR screens identify cholesterol biosynthesis as a therapeutic target on stemness and drug resistance of colon cancer

7 Oct 2021

Abstract excerpt

Cancer stem cells (CSCs) are responsible for tumor progression, recurrence, and drug resistance. To identify genetic vulnerabilities of colon cancer, we performed targeted CRISPR dropout screens comprising 657 Drugbank targets and 317 epigenetic regulators on two patient-derived colon CSC-enriched spheroids. Next-generation sequencing of pooled genomic DNAs isolated from surviving cells yielded therapeutic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Cholesterol and Lipid Metabolism
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34621019
DOI: 10.1038/s41388-021-01882-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CRISPR screens identify cholesterol biosynthesis as a therapeutic target on stemness and drug resistance of colon cancerPMID 34621019Read ↗

A TOX-ic axis of epigenetic stem cell maintenance and chemoresistance in colon cancer.Semantic proximity Read ↗

Non-Canonical Hedgehog Signaling Is a Positive Regulator of the WNT Pathway and Is Required for the Survival of Colon Cancer Stem CellsSemantic proximity Read ↗

Clinical Implications of Colorectal Cancer Stem Cells in the Age of Single-Cell Omics and Targeted TherapiesSemantic proximity Read ↗

Cancer Stem Cell-Based Models of Colorectal Cancer Reveal Molecular Determinants of Therapy ResistanceSemantic proximity Read ↗

Multi-omics, organoid-based modeling reveals an SRC/mTOR-dependent fetal-like stem cell trajectory in colorectal cancerSemantic proximity Read ↗

Establishment of Highly Tumorigenic Human Colorectal Cancer Cell Line (CR4) with Properties of Putative Cancer Stem CellsSemantic proximity Read ↗

Comprehensive Genomic Dependency Landscape of Human Colon CancerSemantic proximity Read ↗

Signaling in colon cancer stem cellsSemantic proximity Read ↗

StarD5 Regulates Cholesterol Homeostasis to Promote Colorectal Cancer Progression and the Cancer Stem Cell Phenotype.Semantic proximity Read ↗

RNA-Sequencing of Long-Term Label-Retaining Colon Cancer Stem Cells Identifies Novel Regulators of QuiescenceSemantic proximity Read ↗

Tumor Initiating Cells and Chemoresistance: Which Is the Best Strategy to Target Colon Cancer Stem Cells?Semantic proximity Read ↗

Suppression of Glucosylceramide Synthase Reverses Drug Resistance in Cancer Cells Harboring Homozygous p53 Mutants.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.